Safe Injecting Facilities (SIFs) have been operating in various locations across the developed world for over 20years (). Typically physically located in close proximity to established drug market and drug injecting precincts, SIFs provide a sanctioned space for the injection of drugs (). These ‘enabling environments’ () have been shown to have a range of public health benefits, from improvements in the management and response to acute drug overdose (), through to successful referral to other services ().